These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6539574)

  • 1. Reverse fibrin autography: a method to detect and partially characterize protease inhibitors after sodium dodecyl sulfate--polyacrylamide gel electrophoresis.
    Erickson LA; Lawrence DA; Loskutoff DJ
    Anal Biochem; 1984 Mar; 137(2):454-63. PubMed ID: 6539574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for the presence of two different fibrinolytic inhibitors in human endothelial cell conditioned medium.
    Sprengers ED; Verheijen JH; Van Hinsbergh VW; Emeis JJ
    Biochim Biophys Acta; 1984 Sep; 801(2):163-70. PubMed ID: 6541058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of an unusually stable fibrinolytic inhibitor produced by bovine endothelial cells.
    Loskutoff DJ; van Mourik JA; Erickson LA; Lawrence D
    Proc Natl Acad Sci U S A; 1983 May; 80(10):2956-60. PubMed ID: 6574465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrin autography of plasminogen activator by electrophoretic transfer into fibrin agar gels.
    Brunner G; Schirrmacher V
    Anal Biochem; 1988 Feb; 168(2):411-6. PubMed ID: 3364738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection and partial characterization of a specific plasminogen activator inhibitor in human chondrocyte cultures.
    Yamada H; Stephens RW; Nakagawa T; McNicol D
    J Biochem; 1988 Dec; 104(6):960-7. PubMed ID: 3149640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of human tumor cell-associated fibrinolysis by vascular bovine smooth muscle cells.
    Laug WE
    J Natl Cancer Inst; 1985 Aug; 75(2):345-52. PubMed ID: 3860687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromogenic substrate autography: a method for detection, characterization, and quantitative measurement of serine proteases after sodium dodecyl sulfate-polyacrylamide gel electrophoresis or isoelectric focusing in polyacrylamide gels.
    Wagner OF; Bergmann I; Binder BR
    Anal Biochem; 1985 Nov; 151(1):7-12. PubMed ID: 3911825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Habutobin releases plasminogen activator (U-PA) from bovine pulmonary artery endothelial cells.
    Sunagawa M; Hanashiro K; Nakamura M; Kosugi T
    Toxicon; 1996 Jun; 34(6):691-9. PubMed ID: 8817813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular and extracellular plasminogen activator and inhibitor in an experimental tumour.
    Dong Q; Zhou MH; Subbarao V; Ts'ao CH
    Br J Exp Pathol; 1988 Oct; 69(5):685-95. PubMed ID: 3143395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of proteases and protease-inhibitor complexes in biological fluids.
    Granelli-Piperno A; Reich E
    J Exp Med; 1978 Jul; 148(1):223-34. PubMed ID: 78958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different molecular forms of plasminogen and plasmin produced by urokinase in human plasma and their relation to protease inhibitors and lysis of fibrinogen and fibrin.
    Müllertz S
    Biochem J; 1974 Nov; 143(2):273-83. PubMed ID: 4282470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The primary plasminogen-activator inhibitors in endothelial cells, platelets, serum, and plasma are immunologically related.
    Erickson LA; Hekman CM; Loskutoff DJ
    Proc Natl Acad Sci U S A; 1985 Dec; 82(24):8710-4. PubMed ID: 3936043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interfering factors in the assay of plasminogen activators by the fibrin plate method. Occurrence of different inhibitors against tissue plasminogen activator and urokinase.
    Wijngaards G
    Thromb Haemost; 1979 May; 41(3):590-600. PubMed ID: 111368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urokinase and non-urokinase fibrinolytic activity in protease-inhibitor-deprived plasma, assayed by a fibrin micro-plate method.
    Fossum S; Hoem NO
    Immunopharmacology; 1996 May; 32(1-3):119-21. PubMed ID: 8796286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between fibrin and the plasminogen activators produced by cultured endothelial cells.
    Loskutoff DJ; Mussoni L
    Blood; 1983 Jul; 62(1):62-8. PubMed ID: 6683113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cleavage of surfactant-incorporating fibrin by different fibrinolytic agents. Kinetics of lysis and rescue of surface activity.
    Günther A; Markart P; Kalinowski M; Ruppert C; Grimminger F; Seeger W
    Am J Respir Cell Mol Biol; 1999 Dec; 21(6):738-45. PubMed ID: 10572071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serpin inhibitors of urokinase and thrombin in normal rat brain and the 9L brain tumor: evidence for elevated expression of protease nexin I-like inhibitor and a novel sodium dodecyl sulfate-activated tumor antithrombin.
    Rao JS; Baker JB; Morantz RA; Kimler B; Evans R; Festoff BW
    Cancer Res; 1990 Aug; 50(16):5039-44. PubMed ID: 2116223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cultured granulosa cells produce two plasminogen activators and an antiactivator, each regulated differently by gonadotropins.
    Ny T; Bjersing L; Hsueh AJ; Loskutoff DJ
    Endocrinology; 1985 Apr; 116(4):1666-8. PubMed ID: 3918858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors contributing to increased vascular fibrinolytic activity in mongrel dogs.
    Lang IM; Marsh JJ; Konopka RG; Olman MA; Binder BR; Moser KM; Schleef RR
    Circulation; 1993 Jun; 87(6):1990-2000. PubMed ID: 8504514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasminogen activator inhibitor type 1 production by rat type II pneumocytes in culture.
    Parton LA; Warburton D; Laug WE
    Am J Respir Cell Mol Biol; 1992 Feb; 6(2):133-9. PubMed ID: 1540377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.